PTSDNCT07129278
Breathwork Intervention for Posttraumatic Stress
A study testing Breathwork in people with PTSD, run by Florida State University at 2 sites in United States.
Trial summary
The goal of this single-site, single-arm pilot study is to examine the impact of breathwork training for posttraumatic stress symptoms in an adult veteran population. Participants will complete a single, in-person breathwork session (2 hours) led by a certified breathwork facilitator and engage in an integration… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- PTSD
- What is being tested?
- Breathwork
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 36 participants
- Where
- 2 sitesUnited States
- Study dates
- 7 May 2025to 6 Oct 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- (1) having received a professional diagnosis of post-traumatic stress disorder (PTSD)
- (2) being able not to commit to another (new) treatment during the course of the study
- (3) understanding English instructions fluently
- (4) being 18 and above.
Who cannot join
- (1) having been exposed to breathwork any time in the past
- (2) being unable to perform most basic tasks due to PTSD or other mental illness.
- (3) Asthma, breathing problems, or a respiratory disorder (e.g., chronic obstructive pulmonary disease).
- (4) Uncontrolled hypertension (i.e., systolic blood pressure/diastolic blood pressure > 150/95), orthostatic hypotension (e.g., issues with fainting), or cardiovascular or peripheral arterial disease.
- (5) Current or past diagnosis of a neurological disease (e.g., Parkinson's, multiple sclerosis, epilepsy, vasovagal syncope)
- (6) Serious psychiatric disorder requiring hospitalization within the past 12 months
Show all 12Show fewer
- (7) Current substance use disorder or history of hospitalization for treatment of a substance use disorder.
- (8) Current participation in another research study involving an intervention or treatment.
- (9) Currently pregnant
- (10) Any significant comorbidities or issues that, in the opinion of the investigators, could interfere with the study or lead to deleterious effects for the participant.
- (11) Adults unable to consent
- (12) Prisoners
Trial locations and contacts
2 sites in 1 country.
United States2 sites
Diamond Rose Sanctuary
Branford, Connecticut, 06405
Florida State University
Tallahassee, Florida, 32306
About this study
Official title: Breathwork Intervention for Individuals With Post-Traumatic Stress Symptoms
The goal of this single-site, single-arm pilot study is to examine the impact of breathwork training for posttraumatic stress symptoms in an adult veteran population. Participants will complete a single, in-person breathwork session (2 hours) led by a certified breathwork facilitator and engage in an integration session (30 minute) with a licensed psychologist. Participants will be invited to engage in two, optional, virtual follow up breathwork sessions (40 minute practice each) during weeks 2 and 3 following the in-person breathwork session.
- Conditions
- PTSD
- Being tested
- Breathwork
- Keywords
- PTSD, Breathwork, Contemplative practice, Cyclic sighing
- Medical subject headings
- Stress Disorders, Post-Traumatic
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
BreathworkBehavioural
Participants will complete their single-session, 2-hour training in a small group with the Breathwork instructor.
| Study group | Role | What they receive |
|---|---|---|
| Active Treatment | Experimental | All participants will be assigned to breathwork. Receives: Behavioral: Breathwork |
What is being measured
The primary outcome is the main question the study is designed to answer.
Recruitment Feasibility
The primary outcome of recruitment feasibility will be assessed by the ability to enroll 30 eligible participants by September 30, 2025. This will inform the practicality of recruitment strategies for a future definitive trial.
Measured: From date of first participant contact (May 6th) to the day before the final breathwork session (10th of October): 158 days
Retention
≥80% of enrolled participants completing all study procedures through final follow-up.
Measured: From baseline assessment (-2 weeks) to 13-week follow-up: 15 week span
Acceptability of Intervention Measure (AIM)
Acceptability of Intervention Measure (AIM) is a 4-item scale. It uses a 5-point ordinal scale for each item, ranging from "Completely Disagree" to "Completely Agree". Scores are typically calculated as either the mean or total of the responses, with higher scores indicating greater acceptability.
Measured: Administered once at the conclusion of the in-person integration session (approx. 30 minutes post-intervention)
Intervention Appropriateness Measure (IAM)
Intervention Appropriateness Measure (IAM) is a 4-item scale. It uses a 5-point ordinal scale for each item, ranging from "Completely Disagree" to "Completely Agree". Scores are typically calculated as either the mean or total of the responses, with higher scores indicating greater appropriateness.
Measured: Administered once at the conclusion of the in-person integration session (approx. 30 minutes post-intervention)
Feasibility of Intervention Measure (FIM)
Feasibility of Intervention Measure (FIM) is a 4-item scale. It uses a 5-point ordinal scale for each item, ranging from "Completely Disagree" to "Completely Agree". Scores are typically calculated as either the mean or total of the responses, with higher scores indicating greater feasibility.
Measured: Administered once at the conclusion of the in-person integration session (approx. 30 minutes post-intervention)
Acupuncture Expectancy Scale (AES)
The Acupuncture Expectancy Scale (AES) is a 4-item scale. It uses a 5-point Likert scale for each item, and a higher total score (ranging from 4 to 20) indicates greater expectancy of benefit from acupuncture.
Measured: Administered once at the conclusion of the in-person integration session (approx. 30 minutes post-intervention)
Secondary outcomes (23)
Post-Traumatic Stress Disorder Checklist for DSM-5 (PCL-5)
The PCL-5 is a 20-item self-report measure. It is scored by summing the ratings for each of the 20 items. Each item is rated on a 5-point scale (0-4), where 0 means "Not at all" and 4 means "Extremely". The total score, ranging from 0 to 80, represents the severity of PTSD symptoms.
Measured: Baseline (-2 weeks), 4-week follow up, 8-week follow up and 13-week follow-up: 15 week span
Brief Trauma Questionnaire (BTQ)
The BTQ is a 10-item instrument that lists a number of difficult of stressful things that sometimes happen to people. The Brief Trauma Questionnaire (BTQ) is scored by counting the number of traumatic events experienced that meet DSM-IV "Criterion A" criteria (life threat or serious injury). Each of the 10 items on the BTQ is scored as positive if the respondent reports experiencing the event and also reports either life threat or serious injury (depending on the specific question). A higher score indicates a greater number of traumatic events experienced
Measured: Baseline (-2 weeks), 4-week follow up, 8-week follow up and 13-week follow-up: 15 week span
Posttraumatic Growth Inventory (PGI)
Posttraumatic growth will be assessed with the 21-item Posttraumatic Growth Inventory (PGI). It is scored by summing responses to its 21 items, each rated on a 6-point Likert scale. The total score ranges from 0 to 105, with higher scores indicating greater perceived post-traumatic growth. Scores on the five subscales (Relating to Others, New Possibilities, Personal Strength, Spiritual Change, and Appreciation of Life) are calculated by averaging the relevant items within each subscale.
Measured: Baseline (-2 weeks), 4-week follow up, 8-week follow up and 13-week follow-up: 15 week span
Patient Health Questionnaire 2-item (PHQ-2)
The Patient Health Questionnaire 2-item (PHQ-2) is scored by summing the responses to its two questions. Each question offers four possible responses, scored from 0 to 3, with 0 being "not at all" and 3 being "nearly every day". A total score is calculated by adding the scores of both questions, resulting in a range from 0 to 6. A score of 3 or higher suggests further evaluation for depression
Measured: Baseline; 2-week follow up; 6-week follow up.
Generalized Anxiety Disorder-2 (GAD-2)
Patients will note their anxiety with the Generalized Anxiety Disorder-2 (GAD-2). This 2-item scale is scored by summing the responses to two questions, each rated on a 4-point scale. The possible scores for each item range from 0 to 3, with 0 representing "Not at all" and 3 representing "Nearly every day". The total score, which ranges from 0 to 6, is then calculated by adding the scores of the two items. A higher score indicates a greater likelihood of anxiety.
Measured: Baseline (-2 weeks), 4-week follow up, 8-week follow up and 13-week follow-up: 15 week span
Pain, Enjoyment of Life, and General Activity Scale (PEG)
Participants will be asked about their pain intensity and pain interference with the Pain, Enjoyment of Life and General Activity (PEG) Scale. The 11-item Likert scale is scored by averaging the responses to three questions, each rated on a scale of 0 to 10. A higher score indicates a greater impact of pain.
Measured: Baseline (-2 weeks), 4-week follow up, 8-week follow up and 13-week follow-up: 15 week span
PROMIS Sleep Disturbance 6a + Sleep Duration
The PROMIS Sleep Disturbance 6a and Sleep Duration measures are scored by first summing the responses to the individual items, then converting the raw sum score to a standardized T-score using conversion tables. The PROMIS Sleep Disturbance 6a uses a 5-point Likert scale for each item, and the Sleep Duration is a separate item with its own scoring. The T-score represents the individual's sleep disturbance relative to a reference population (mean of 50, standard deviation of 10).
Measured: Baseline (-2 weeks), 4-week follow up, 8-week follow up and 13-week follow-up: 15 week span
PROMIS v1.0 Alcohol Use - Short Form 7a
The PROMIS v1.0 Alcohol Use - Short Form 7a is a 7-item questionnaire using a 5-point Likert scale (1- never to 5- almost always). It is scored by summing the responses to each question, where each question has a 5-point Likert scale. Higher scores indicate stronger positive expectancies about alcohol use. The raw score is then converted to a T-score for comparison with a normative sample.
Measured: Baseline (-2 weeks), 4-week follow up, 8-week follow up and 13-week follow-up: 15 week span
Smoking: Nicotine Dependence for All Smokers - Short Form 4a
The Smoking: Nicotine Dependence for All Smokers - Short Form 4a is a 4-item questionnaire using a 5-point Likert scale (1-never, 5-always). The Smoking: Nicotine Dependence for All Smokers - Short Form 4a is scored by summing the values of the responses to each of its four items. Each item has five possible response options, ranging from 1 to 5, with higher scores indicating greater nicotine dependence. The total raw score ranges from 4 (lowest dependence) to 20 (highest dependence).
Measured: Baseline (-2 weeks), 4-week follow up, 8-week follow up and 13-week follow-up: 15 week span
Patient Global Impression of Change (PGIC)
The PGIC is a single-item, seven-point scale used to assess a patient's perception of change in their condition since a specific point in time. The scale ranges from "very much worse" to "very much improved". Higher scores indicate greater improvement, while lower scores indicate worsening or no change.
Measured: Baseline (-2 weeks), 4-week follow up, 8-week follow up and 13-week follow-up: 15 week span
Nondual Awareness Dimensional Assessment (NADA-State)
Participants will complete the 3-item, state version of the Nondual Awareness Dimensional Assessment. The NADA is scored 0-10 and responses are averaged across the 3-items. A higher score is indicative of a greater self-transcendent state.
Measured: From immediately before to immediately after the in-person breathwork session (approximately 2-hour span); and from immediately before to immediately after each optional virtual follow-up session.
Emotional Breakthrough Inventory (EBI)
The Emotional Breakthrough Inventory is a 6-item questionnaire to assess emotional breakthrough resulting from an experience. It is scored 0-10 and scores are summed, with a higher score being indicative of a greater emotional breakthrough.
Measured: From immediately before to immediately after the in-person breathwork session (approximately 2-hour span); and from immediately before to immediately after each optional virtual follow-up session.
Perceived Body Boundary Scale (PBBS)
The Perceived Body Boundary Scale is a single visual item used to assess the strength of the boundary between the self and the world using a 7-point Likert type scale (1=Weak boundary, 7=Strong boundary).
Measured: From immediately before to immediately after the in-person breathwork session (approximately 2-hour span); and from immediately before to immediately after each optional virtual follow-up session.
Spatial Frame of Reference Continuum (SFoRC)
The single-item Spatial Frame of Reference Continuum describes a spectrum of ways individuals and organisms represent and interact with spatial information, ranging from response A (self-centered (egocentric)) to response G (world-centered (allocentric) perspectives). Response G indicates the highest level of world-centered perspective.
Measured: From immediately before to immediately after the in-person breathwork session (approximately 2-hour span); and from immediately before to immediately after each optional virtual follow-up session.
Inclusion of Other in Self Scale (IOS)
The Inclusion of Other in Self (IOS) is a single-item scale. It is scored by having the respondent select one of seven pairs of overlapping circles that best represents their relationship with another person or group. Each pair of circles represents a different level of overlap, from completely separate (1) to almost completely overlapping (7). The chosen number (1-7) serves as the score, indicating the degree of perceived closeness and interconnectedness.
Measured: From immediately before to immediately after the in-person breathwork session (approximately 2-hour span); and from immediately before to immediately after each optional virtual follow-up session.
Nondual Awareness Dimensional Assessment-Trait (NADA-T)
The 13-item Nondual Awareness Dimensional Assessment-Trait (NADA-T) will be used to assess traits of consciousness. The Nondual Awareness Dimensional Assessment-Trait (NADA-T) is scored by summing responses to 13 items, each on a 5-point Likert scale, ranging from "never or very rarely" to "very often or always". The scale assesses two dimensions of nondual awareness: self-transcendence and bliss. The total score can range from 13 to 65, with higher scores indicating a greater experience of nondual awareness.
Measured: From immediately before to immediately after the in-person breathwork session (approximately 2-hour span); and from immediately before to immediately after each optional virtual follow-up session.
Integration Engagement Scale (IES)
The Integration Engagement Scale is a 12-item questionnaire used to measure positive behavioral engagement with integration. Participants are asked to rate their experiences on a 5-point Likert scale (0 = not at all to 4 = extremely). The IES yields a total score, typically ranging from 0 to 60. Higher scores on the IES generally indicate increased positive behavioral engagement with integration.
Measured: 4-week follow up, 8-week follow up and 13-week follow-up
Experienced Integration Scale (EIS)
The Experienced Integration Scale is a 12-item questionnaire to capture internal aspects of feeling integrated. Participants are asked to rate their experiences on a 5-point Likert scale (1- strongly disagree to 5=strongly agree). Items are summed; a higher score indicates greater feelings of integration.
Measured: 4-week follow up, 8-week follow up and 13-week follow-up
Whole Person Health Index
The Whole Person Health Index (WPHI) is a 9-item survey. It is scored by The WPHI can be calculated by summing the nine response scores, such that, over time, for example, an individual's WPHI going from 45 to 25 would indicate an improvement in overall self-assessed health
Measured: 4-week follow up, 8-week follow up and 13-week follow-up
Brief Inventory of Psychosocial Functioning (B-IPF)
Psychosocial functioning will be assessed using the Brief Inventory of Psychosocial Functioning (B-IPF), a validated 7-item self-report instrument designed to measure psychosocial impairment across key life domains. Each item is rated on a 7-point Likert scale ranging from 0 ("Not at all") to 6 ("Very much"), with higher scores indicating greater psychosocial impairment. The total score is calculated by summing responses across all items, yielding a possible range of 0 to 42.
Sample item: "I had trouble in my romantic relationship with my spouse or partner.
Measured: Baseline (-2 weeks), 4-week follow up, 8-week follow up and 13-week follow-up: 15 week span
Single-Item State Anxiety Measure
State anxiety will be measured using a single item adapted from the Generalized Anxiety Disorder 2-item (GAD-2) scale: "Right now, to what extent are you feeling… nervous, anxious, or on edge?" Participants respond using a 7-point Likert scale ranging from 0 ("Not at all") to 6 ("Extremely"), with higher scores indicating greater state anxiety.
Measured: From immediately before to immediately after the in-person breathwork session (approximately 2-hour span); and from immediately before to immediately after each optional virtual follow-up session.
Single-Item State Optimism Measure
State optimism will be assessed using a single item adapted from the State Optimism Measure: "Right now, to what extent are you feeling… optimistic about life's challenges?" Participants respond using a 7-point Likert scale ranging from 0 ("Not at all") to 6 ("Extremely"), with higher scores indicating greater state optimism.
Measured: From immediately before to immediately after the in-person breathwork session (approximately 2-hour span); and from immediately before to immediately after each optional virtual follow-up session.
Single-Item State Relaxation Measure
State relaxation will be measured using a single item adapted from the Relaxation State Questionnaire: "Right now, to what extent are you feeling… refreshed and awake?" Participants respond using a 7-point Likert scale ranging from 0 ("Not at all") to 6 ("Extremely"), with higher scores indicating greater relaxation or alertness.
Measured: From immediately before to immediately after the in-person breathwork session (approximately 2-hour span); and from immediately before to immediately after each optional virtual follow-up session.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Aug 2025
- Study start7 May 2025
- Primary completion6 Oct 2025
- Study completion6 Oct 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PTSDStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 36 participants (actual)
Sponsor and investigators
- Lead sponsor
- Florida State University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Adam Hanley, Florida State University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07129278
- Sponsor's protocol ID
- STUDY00005111
- Status last verified
- Apr 2026
- First submitted
- 30 Apr 2025
- Last updated
- 6 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Data may be shared with qualified researchers upon request.
Study at a glance
From the registry record, last updated by the sponsor on 6 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Breathwork Intervention for Individuals With Post-Traumatic Stress Symptoms
- ClinicalTrials.gov ID
- NCT07129278
- Acronym / sponsor ID
- STUDY00005111
- Conditions
- PTSD
- Keywords
- PTSD, Breathwork, Contemplative practice, Cyclic sighing
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 36 participants (actual)
- Lead sponsor
- Florida State UniversityUniversity, hospital or other
- Study start
- 7 May 2025 (actual)
- Primary completion
- 6 Oct 2025 (actual)
- Study completion
- 6 Oct 2025 (actual)
- First posted
- 19 Aug 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this single-site, single-arm pilot study is to examine the impact of breathwork training for posttraumatic stress symptoms in an adult veteran population. Participants will complete a single, in-person breathwork session (2 hours) led by a certified breathwork facilitator and engage in an integration session (30 minute) with a licensed psychologist. Participants will be invited to engage in two, optional, virtual follow up breathwork sessions (40 minute practice each) during weeks 2 and 3 following the in-person breathwork session.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Active Treatment | Experimental | Behavioral: BreathworkAll participants will be assigned to breathwork. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- (1) having received a professional diagnosis of post-traumatic stress disorder (PTSD)
- (2) being able not to commit to another (new) treatment during the course of the study
- (3) understanding English instructions fluently
- (4) being 18 and above.
Key exclusion criteria (12 listed)
- (1) having been exposed to breathwork any time in the past
- (2) being unable to perform most basic tasks due to PTSD or other mental illness.
- (3) Asthma, breathing problems, or a respiratory disorder (e.g., chronic obstructive pulmonary disease).
- (4) Uncontrolled hypertension (i.e., systolic blood pressure/diastolic blood pressure > 150/95), orthostatic hypotension (e.g., issues with fainting), or cardiovascular or peripheral arterial disease.
- (5) Current or past diagnosis of a neurological disease (e.g., Parkinson's, multiple sclerosis, epilepsy, vasovagal syncope)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| BreathworkParticipants will complete their single-session, 2-hour training in a small group with the Breathwork instructor. | Behavioural | Active Treatment |
Primary outcome
Recruitment Feasibility
Time frame: From date of first participant contact (May 6th) to the day before the final breathwork session (10th of October): 158 days
The primary outcome of recruitment feasibility will be assessed by the ability to enroll 30 eligible participants by September 30, 2025. This will inform the practicality of recruitment strategies for a future definitive trial.
Retention
Time frame: From baseline assessment (-2 weeks) to 13-week follow-up: 15 week span
≥80% of enrolled participants completing all study procedures through final follow-up.
Acceptability of Intervention Measure (AIM)
Time frame: Administered once at the conclusion of the in-person integration session (approx. 30 minutes post-intervention)
Acceptability of Intervention Measure (AIM) is a 4-item scale. It uses a 5-point ordinal scale for each item, ranging from "Completely Disagree" to "Completely Agree". Scores are typically calculated as either the mean or total of the responses, with higher scores indicating greater acceptability.
Intervention Appropriateness Measure (IAM)
Time frame: Administered once at the conclusion of the in-person integration session (approx. 30 minutes post-intervention)
Intervention Appropriateness Measure (IAM) is a 4-item scale. It uses a 5-point ordinal scale for each item, ranging from "Completely Disagree" to "Completely Agree". Scores are typically calculated as either the mean or total of the responses, with higher scores indicating greater appropriateness.
Feasibility of Intervention Measure (FIM)
Time frame: Administered once at the conclusion of the in-person integration session (approx. 30 minutes post-intervention)
Feasibility of Intervention Measure (FIM) is a 4-item scale. It uses a 5-point ordinal scale for each item, ranging from "Completely Disagree" to "Completely Agree". Scores are typically calculated as either the mean or total of the responses, with higher scores indicating greater feasibility.
Acupuncture Expectancy Scale (AES)
Time frame: Administered once at the conclusion of the in-person integration session (approx. 30 minutes post-intervention)
The Acupuncture Expectancy Scale (AES) is a 4-item scale. It uses a 5-point Likert scale for each item, and a higher total score (ranging from 4 to 20) indicates greater expectancy of benefit from acupuncture.
23 secondary outcomes
Post-Traumatic Stress Disorder Checklist for DSM-5 (PCL-5)
Time frame: Baseline (-2 weeks), 4-week follow up, 8-week follow up and 13-week follow-up: 15 week span
Brief Trauma Questionnaire (BTQ)
Time frame: Baseline (-2 weeks), 4-week follow up, 8-week follow up and 13-week follow-up: 15 week span
Posttraumatic Growth Inventory (PGI)
Time frame: Baseline (-2 weeks), 4-week follow up, 8-week follow up and 13-week follow-up: 15 week span
Patient Health Questionnaire 2-item (PHQ-2)
Time frame: Baseline; 2-week follow up; 6-week follow up.
Generalized Anxiety Disorder-2 (GAD-2)
Time frame: Baseline (-2 weeks), 4-week follow up, 8-week follow up and 13-week follow-up: 15 week span
Pain, Enjoyment of Life, and General Activity Scale (PEG)
Time frame: Baseline (-2 weeks), 4-week follow up, 8-week follow up and 13-week follow-up: 15 week span
PROMIS Sleep Disturbance 6a + Sleep Duration
Time frame: Baseline (-2 weeks), 4-week follow up, 8-week follow up and 13-week follow-up: 15 week span
PROMIS v1.0 Alcohol Use - Short Form 7a
Time frame: Baseline (-2 weeks), 4-week follow up, 8-week follow up and 13-week follow-up: 15 week span
Smoking: Nicotine Dependence for All Smokers - Short Form 4a
Time frame: Baseline (-2 weeks), 4-week follow up, 8-week follow up and 13-week follow-up: 15 week span
Patient Global Impression of Change (PGIC)
Time frame: Baseline (-2 weeks), 4-week follow up, 8-week follow up and 13-week follow-up: 15 week span
Nondual Awareness Dimensional Assessment (NADA-State)
Time frame: From immediately before to immediately after the in-person breathwork session (approximately 2-hour span); and from immediately before to immediately after each optional virtual follow-up session.
Emotional Breakthrough Inventory (EBI)
Time frame: From immediately before to immediately after the in-person breathwork session (approximately 2-hour span); and from immediately before to immediately after each optional virtual follow-up session.
Perceived Body Boundary Scale (PBBS)
Time frame: From immediately before to immediately after the in-person breathwork session (approximately 2-hour span); and from immediately before to immediately after each optional virtual follow-up session.
Spatial Frame of Reference Continuum (SFoRC)
Time frame: From immediately before to immediately after the in-person breathwork session (approximately 2-hour span); and from immediately before to immediately after each optional virtual follow-up session.
Inclusion of Other in Self Scale (IOS)
Time frame: From immediately before to immediately after the in-person breathwork session (approximately 2-hour span); and from immediately before to immediately after each optional virtual follow-up session.
Nondual Awareness Dimensional Assessment-Trait (NADA-T)
Time frame: From immediately before to immediately after the in-person breathwork session (approximately 2-hour span); and from immediately before to immediately after each optional virtual follow-up session.
Integration Engagement Scale (IES)
Time frame: 4-week follow up, 8-week follow up and 13-week follow-up
Experienced Integration Scale (EIS)
Time frame: 4-week follow up, 8-week follow up and 13-week follow-up
Whole Person Health Index
Time frame: 4-week follow up, 8-week follow up and 13-week follow-up
Brief Inventory of Psychosocial Functioning (B-IPF)
Time frame: Baseline (-2 weeks), 4-week follow up, 8-week follow up and 13-week follow-up: 15 week span
Single-Item State Anxiety Measure
Time frame: From immediately before to immediately after the in-person breathwork session (approximately 2-hour span); and from immediately before to immediately after each optional virtual follow-up session.
Single-Item State Optimism Measure
Time frame: From immediately before to immediately after the in-person breathwork session (approximately 2-hour span); and from immediately before to immediately after each optional virtual follow-up session.
Single-Item State Relaxation Measure
Time frame: From immediately before to immediately after the in-person breathwork session (approximately 2-hour span); and from immediately before to immediately after each optional virtual follow-up session.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 May 2026.
- Individual participant dataSharing planned: Yes. Data may be shared with qualified researchers upon request.
Related trials for PTSD
RecruitingPhase 1
Open-Label Psilocybin Study in Transdiagnostic Population
Transdiagnostic, Depression - Major Depressive Disorder
Not yet recruitingPhase 2
Assessing of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies
PTSD, PTSD - Post Traumatic Stress Disorder
Active, not recruitingObservational study
Trauma-Related Attributions in Trauma Treatment: An Observational Study
PTSD
Not yet recruiting
Multimodal Intervention for Individuals With Posttraumatic Stress Disorder (PTSD) and Hazardous Alcohol Use
Post Traumatic Stress Disorder PTSD, Hazardous Alcohol Use
Recruiting
Early Intervention for Postpartum PTSD: Comparing Written Exposure and Capnometry-Guided Breathing Therapy
Written Exposure Therapy, Breathing Techniques
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Breathwork in people with PTSD, run by Florida State University at 2 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 6 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Recruitment Feasibility (time frame: From date of first participant contact (May 6th) to the day before the final breathwork session (10th of October): 158 days). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2026.